11:20 AM EDT, 10/07/2024 (MT Newswires) -- Akoya Biosciences ( AKYA ) said Monday that its spatial proteomics platforms will be used to analyze tissue samples as part of the Multiomic Analysis of Immunotherapy Features Evidencing Success and Toxicity, or MANIFEST, program.

The initiative, funded by the UK Office of Life Sciences and the Medical Research Council, seeks to enhance cancer immunotherapy research through in-depth multi-omic profiling.

The MANIFEST consortium will analyze tissue samples from cancer patients using Akoya's platforms, starting with 6,000 patients with breast, bladder, kidney and skin cancers.

Price: 3.20, Change: +0.42, Percent Change: +15.04